Positive troponin in diabetic ketoacidosis without evident acute coronary syndrome predicts adverse cardiac events

Clinical Cardiology

Volumn 31, Issue 2, 2008, Pages 67-71

  Al Mallah, Mouaz ^a   Zuberi, Omar ^a   Arida, Muhammad ^a   Kim, Henry E ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Diabetes; Diabetic ketoacidosis; Outcomes; Troponin

Indexed keywords

TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RESEARCH DESIGN; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TROPONIN I;

EID: 39849102487     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20167     Document Type: Article

References (23)

1. Delaney MF, Zisman A, Kettyle WM: Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Endocrinol Metab Clin North Am 2000;29:683-705
2. Krentz AJ, Natrass M: Acute metabolic complications of diabetes mellitus: diabetic ketoacidosis, hyperosmolar non-ketotic syndrome and lactic acidosis. In Textbook of Diabetes (2nd ed.) (Eds. Pickup JC, Williams G), pp 1-23. Oxford: Blackwell Sciences, 1997,; 39
3. Amman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, et al.: Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-1349
4. Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM. Go AS, et al.: The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 2001;38:478-485
5. Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, et al.: Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction. JAMA 2001;286:2405-2412
6. Ammann P, Maggiorini M, Bertel O, Haenseler E, Joller-Jemelka HI, et al.: Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003;41:2004-2009
7. Guest TM, Ramanathan AV, Tuteur PG, Schechtman KB, Ladenson JH, et al.: Myocardial injury in critically ill patients: a frequently unrecognized complication. JAMA 1995;273:1945-1949
8. Dierkes J, Domrose U, Westphal S, Ambrosch A, Bosselmann HP, et al.: Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000;102:1964-1969
9. Giannitsis E, Muller-Bardorff M, Kurowski V, Weidtmann B, Wiegand U, et al.: Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000;102:211-217
10. Pham MX, Whooley MA, Evans GT Jr, Liu C, Emadi H, et al.: Prognostic value of low-level troponin-I elevation in patients without definite acute coronary syndromes. Am Heart J 2004;148:776-82
11. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-234
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
13. Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA: Management of hyperglycemic crises in patients with diabetes mellitus (Technical Review). Diabetes Care 2001;24:131-153
14. American Diabetes Association Position Statement: Hyperglycemic crises in patients with diabetes mellitus. Diabetes Care 2003;26:S109-S117
15. Alpert JS, Thygesen K, Antman E, Bassand JP: Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969
16. Kollef MH, Ladenson JH, Eisenberg PR: Clinically recognized cardiac dysfunction: an independent determinant of mortality among critically ill patients. Chest 1997;111:1340-1347
17. Wright SA, Sawyer DB, Sacks DB, Chyu S, Goldhaber SZ: Elevation of troponin I levels in patients without evidence of myocardial injury. JAMA 1997;278(24):2144
18. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey Ja, et al.: Detection of ischemia in asymptomatic Diabetics Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD Study. Diabetes Care 2004;27:1954-1961
19. Sultan A, Piot C, Mariano-Goulart D, Rasamisoa M, Renard E, et al.: Risk factors for silent myocardial ischemia in high-risk type 1 diabetic patients. Diabetes Care 2004;27:1745-1747
20. Deedwania PC: Diabetes is a vascular disease: the role of endothelial dysfunction in pathophysiology of cardiovascular disease in diabetes. Cardiol Clin 2004;22:505-509
21. Atabek ME, Pirgon O, Oran B, Erkul I, Kurtoglu S: Increased cardiac troponin 1 concentration in diabetic ketoacidosis. J Pediatr Endocrinol Metah 2004;17:1077-1082
22. Mehta SR, Cannon CP, Fox KA, Wallentin L, Boden WE, et al.: Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 2005;293:2908-2917
23. Stukel TA, Lucas FL. Wennberg DE: Long-term Outcomes of Regional Variations in Intensity of Invasive vs. Medical Management of Medicare Patients with Acute Myocardial Infarction. JAMA 2005;293:1329-1337